Mouse embryonic fibroblasts from CD38 knockout mice are resistant to oxidative stresses through inhibition of reactive oxygen species production and Ca2+ overload

Biochemical and Biophysical Research Communications

Volumn 399, Issue 2, 2010, Pages 167-172

  Ge, Yan ^a   Jiang, Wei ^a   Gan, Lu ^a   Wang, Lijun ^a   Sun, Changyan ^a   Ni, Peiyan ^a   Liu, Yin ^a   Wu, Sisi ^a   Gu, Lunda ^a   Zheng, Wei ^a   Lund, Frances E ^b   Xin, Hong Bo ^a,c  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c NANCHANG UNIVERSITY   (China)

Author keywords

Ca2+; CD38; Nox1; ROS

Indexed keywords

CALCIUM; CD38 ANTIGEN; IONOMYCIN; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; CELL VIABILITY; EMBRYO; FIBROBLAST; HYPOXIA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION;

ANIMALS; ANTIGENS, CD38; CALCIUM; EMBRYO, MAMMALIAN; FIBROBLASTS; MICE; MICE, KNOCKOUT; NADH, NADPH OXIDOREDUCTASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

MUS;

EID: 77955847017     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.07.040     Document Type: Article

References (36)

1. Ischiropoulos H., al-Mehdi A.B., Fisher A.B. Reactive species in ischemic rat lung injury: contribution of peroxynitrite. Am. J. Physiol. 1995, 269:L158-L164.
2. Ma T.T., Ischiropoulos H., Brass C.A. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology 1995, 108:463-469.
3. Matheis G., Sherman M.P., Buckberg G.D., Haybron D.M., Young H.H., Ignarro L.J. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am. J. Physiol. 1992, 262:H616-H620.
4. Szabo C., Salzman A.L., Ischiropoulos H. Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia/reperfusion injury. FEBS Lett. 1995, 372:229-232.
5. Carrozza J.P., Bentivegna L.A., Williams C.P., Kuntz R.E., Grossman W., Morgan J.P. Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion. Circ. Res. 1992, 71:1334-1340.
6. Piper H.M., Meuter K., Schafer C. Cellular mechanisms of ischemia/reperfusion injury. Ann. Thorac. Surg. 2003, 75:S644-S648.
7. Reinherz E.L., Kung P.C., Goldstein G., Levey R.H., Schlossman S.F. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc. Natl. Acad. Sci. USA 1980, 77:1588-1592.
8. Kramer G., Steiner G., Fodinger D., Fiebiger E., Rappersberger C., Binder S., Hofbauer J., Marberger M. High expression of a CD38-like molecule in normal prostatic epithelium and its differential loss in benign and malignant disease. J. Urol. 1995, 154:1636-1641.
9. Yamada M., Mizuguchi M., Otsuka N., Ikeda K., Takahashi H. Ultrastructural localization of CD38 immunoreactivity in rat brain. Brain Res. 1997, 756:52-60.
10. Li Q., Yamada Y., Yasuda K., Ihara Y., Okamoto Y., Kaisaki P.J., Watanabe R., Ikeda H., Tsuda K., Seino Y. A cloned rat CD38-homologous protein and its expression in pancreatic islets. Biochem. Biophys. Res. Commun. 1994, 202:629-636.
11. Chidambaram N., Wong E.T., Chang C.F. Differential oligomerization of membrane-bound CD38/ADP-ribosyl cyclase in porcine heart microsomes. Biochem. Mol. Biol. Int. 1998, 44:1225-1233.
12. + sensor. FASEB J. 2002, 16:302-314.
13. Lee H.C. Enzymatic functions and structures of CD38 and homologs. Chem. Immunol. 2000, 75:39-59.
14. Graeff R.M., Podein R.J., Aarhus R., Lee H.C. Magnesium ions but not ATP inhibits cyclic ADP-ribose-induced calcium release. Biochem. Biophys. Res. Commun. 1995, 206:786-791.
15. Lee H.C. Potentiation of calcium- and caffeine-induced calcium release by cyclic ADP-ribose. J. Biol. Chem. 1993, 268:293-299.
16. 2+ release in sea urchin egg homogenates: modulation by cyclic ADP-ribose. Science 1991, 253:1143-1146.
17. Churchill G.C., Okada Y., Thomas J.M., Genazzani A.A., Patel S., Galione A. NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs. Cell 2002, 111:703-708.
18. 2+ influx system mediated by LTRPC2. Science 2001, 293:1327-1330.
19. Aksoy P., Escande C., White T.A., Thompson M., Soares S., Benech J.C., Chini E.N. Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. Biochem. Biophys. Res. Commun. 2006, 349:353-359.
20. Aksoy P., White T.A., Thompson M., Chini E.N. Regulation of intracellular levels of NAD: a novel role for CD38. Biochem. Biophys. Res. Commun. 2006, 345:1386-1392.
21. -/- mouse. Biochem. Biophys. Res. Commun. 2006, 346:188-192.
22. Long L.H., Halliwell B. Artefacts in cell culture: pyruvate as a scavenger of hydrogen peroxide generated by ascorbate or epigallocatechin gallate in cell culture media. Biochem. Biophys. Res. Commun. 2009, 388:700-704.
23. Zweier J.L. Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J. Biol. Chem. 1988, 263:1353-1357.
24. Uchigata Y., Yamamoto H., Kawamura A., Okamoto H. Protection by superoxide dismutase, catalase, and poly (ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J. Biol. Chem. 1982, 257:6084-6088.
25. Uchigata Y., Yamamoto H., Nagai H., Okamoto H. Effect of poly (ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis. Diabetes 1983, 32:316-318.
26. Pieper A.A., Brat D.J., Krug D.K., Watkins C.C., Gupta A., Blackshaw S., Verma A., Wang Z.Q., Snyder S.H. Poly (ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 1999, 96:3059-3064.
27. Borchi E., Parri M., Papucci L., Becatti M., Nassi N., Nassi P., Nediani C. Role of NADPH oxidase in H9c2 cardiac muscle cells exposed to simulated ischaemia-reperfusion. J. Cell Mol. Med. 2009, 13:2724-2735.
28. Bedard K., Krause K.H. The Nox family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313.
29. Sumimoto H., Miyano K., Takeya R. Molecular composition and regulation of the Nox family NADPH oxidases. Biochem. Biophys. Res. Commun. 2005, 338:677-686.
30. Bokoch G.M., Knaus U.G. NADPH oxidases: not just for leukocytes anymore!. Trends Biochem. Sci. 2003, 28:502-508.
31. Paravicini T.M., Touyz R.M. NADPH oxidases reactive oxygen species and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 2008, 31(Suppl. 2):S170-S180.
32. Lambeth J.D., Kawahara T., Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic. Biol. Med. 2007, 43:319-331.
33. Malavasi F., Deaglio S., Funaro A., Ferrero E., Horenstein A.L., Ortolan E., Vaisitti T., Aydin S. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol. Rev. 2008, 88:841-886.
34. Xie G.H., Rah S.Y., Yi K.S., Han M.K., Chae S.W., Im M.J., Kim U.H. Increase of intracellular Ca(2+) during ischemia/reperfusion injury of heart is mediated by cyclic ADP-ribose. Biochem. Biophys. Res. Commun. 2003, 307:713-718.
35. 2+ release. Antioxid. Redox. Signal. 2000, 2:47-54.
36. Espino J., Bejarano I., Paredes S.D., Gonzalez D., Barriga C., Reiter R.J., Pariente J.A., Rodriguez A.B. Melatonin counteracts alterations in oxidative metabolism and cell viability induced by intracellular calcium overload in human leucocytes: changes with age. Basic Clin. Pharmacol. Toxicol. 2010, 107:590-597.